DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Edobacomab
Edobacomab
WO 2015/028850 Al 5 March 2015 (05.03.2015) P O P C T
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
(12) Patent Application Publication (10) Pub. No.: US 2015/0250896 A1 Zhao (43) Pub
Pharmaceutical Appendix to the Tariff Schedule 2
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
(12) United States Patent (10) Patent No.: US 8,133,863 B2 Maggio (45) Date of Patent: Mar
(INN) for Biological and Biotechnological Substances
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
Ap Ekarz Polski
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/013551 Al 18 January 2018 (18.01.2018) W !P O PCT
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
Pharmaceuticals Appendix
Top View
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
WO 2013/093809 Al 27 June 2013 (27.06.2013) P O P C T
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Perspectives
(12) United States Patent (10) Patent No.: US 8,314,077 B2 Webb Et Al
WO 2014/093640 Al 19 June 2014 (19.06.2014) P O P C T
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
WO 2U11/1 7921 a L
Wo 2010/095940 A2
Antibody-Drug Analogues
Assessment of the Evolution of Cancer Treatment Therapies
Customs Tariff - Schedule Xxi - 1
Tim Malawi Mai Multe
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2012/109624 A2 16 August 2012 (16.08.2012) P O P C T
(INN) for Biological and Biotechnological Substances
Assessment of the Evolution of Cancer Treatment Therapies
WO 2016/059622 A2 21 April 2016 (21.04.2016) P O P C T
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri